Russian Health Ministry Registers FMBA-Developed COVID-19 Vaccine

While other vaccines prompt an immune response against the coronavirus’ S-protein, the new compound was said to develop antibodies against the N-protein. They usually appear in the natural immune response and provide better protection. The N-protein has less mutagen than the S-protein, which may increase the effectiveness of the new vaccine.